← All trials
NCT01235949
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 12, 2010
- Primary completion
- Mar 28, 2012
- Completion date
- Dec 8, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 850
- Arms / groups
- 18 / —
- Source
- AACT · pre-existing
Sponsors
- GlaxoSmithKlineLead sponsor
- GlaxoSmithKlineStudy director
Drugs studied
- ibuprofen
- ibuprofen
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- acetaminophen
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- pneumococcal 7-valent conjugate vaccine
- pneumococcal 7-valent conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- haemophilus influenzae type b conjugate vaccine
- Inactivated polio virus - Enhanced
- Inactivated polio virus - Enhanced
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.